Closed System Drug Transfer Device CSTD Sales

Closed System Drug Transfer Device (CSTD) Sales Market Outlook

The global Closed System Drug Transfer Device (CSTD) market is projected to reach USD 2.5 billion by 2035, expanding at a CAGR of 8.5% during the forecast period of 2025-2035. Factors contributing to this growth include rising awareness regarding safety measures for handling hazardous drugs, an increasing prevalence of chronic diseases leading to a higher demand for safe drug administration, and significant advancements in technology that enhance the functionality and efficiency of CSTDs. Moreover, stringent regulations imposed by various health organizations regarding the safe handling and transfer of cytotoxic drugs are further propelling the market's growth. As healthcare facilities become more vigilant in ensuring patient and staff safety, the adoption of CSTDs is expected to increase substantially, making it a pivotal segment of the healthcare industry.

Growth Factor of the Market

The growth of the CSTD market is significantly influenced by the increasing focus on occupational safety and reducing the risk of contamination during drug preparation and administration. With healthcare providers recognizing the importance of protecting both healthcare personnel and patients from the dangers posed by hazardous drugs, CSTDs have become a critical component of safe handling procedures. In addition, the rising incidence of cancer and other chronic diseases necessitates the frequent use of chemotherapy and other potent drugs, further driving the demand for reliable transfer devices. Moreover, advancements in technology that lead to the development of more innovative, user-friendly, and cost-effective CSTDs are also contributing to their increased adoption across various healthcare settings. Furthermore, regulatory bodies worldwide are implementing stricter guidelines regarding the handling of hazardous drugs, compelling healthcare facilities to invest in effective drug transfer systems to comply with these regulations.

Key Highlights of the Market

• The CSTD market is anticipated to witness a robust CAGR of 8.5% from 2025 to 2035.
• Increasing cases of cancer and other chronic diseases are driving the demand for safe drug transfer systems.
• Technological advancements are leading to the development of more sophisticated CSTD solutions.
• Stringent regulations regarding hazardous drug handling are compelling healthcare facilities to adopt CSTDs.
• The rise in awareness regarding occupational safety and health among healthcare professionals is propelling market growth.

By Product Type

Membrane-to-Membrane Systems:

Membrane-to-Membrane systems are among the most advanced designs in the CSTD market, offering a closed system that minimizes the risk of drug exposure. They utilize a two-membrane system that prevents any leaks or spills during the transfer process, ensuring that hazardous drugs remain contained within the device. The demand for these systems is particularly high in oncology settings where the handling of cytotoxic drugs is prevalent. Their ability to provide a high level of safety and reliability enhances their desirability among healthcare providers, leading to their increased adoption. As a result, membrane-to-membrane systems are expected to maintain a significant market share as healthcare facilities prioritize safety and compliance with regulatory standards.

Needleless Systems:

Needleless systems represent an innovative approach in the CSTD market, designed to eliminate the need for needles during drug transfer and administration. This minimizes the risk of needle-stick injuries, thereby enhancing safety for healthcare workers and patients alike. The convenience offered by needleless systems, combined with their ease of use, makes them an attractive option for healthcare settings. As the industry continues to evolve towards more efficient and safer solutions, needleless systems are witnessing rising demand, especially in hospitals and clinics where the frequency of drug administration is high.

Phial Adapters:

Phial adapters serve as essential components in the CSTD market, enabling the secure transfer of medications from vials to syringes or other delivery devices. By providing a closed pathway for drug transfer, these adapters effectively prevent contamination and leakage, ensuring both patient and staff safety. Their widespread application in various healthcare settings, particularly in pharmacy compounding and drug administration, drives their demand. The increasing focus on sterile drug delivery systems is expected to propel the adoption of phial adapters further, making them a crucial segment in the overall CSTD market.

Syringe Adapters:

Syringe adapters are designed to facilitate the safe transfer of hazardous drugs from containers to syringes while maintaining a closed system. They are integral to ensuring that healthcare providers can administer drugs without direct exposure to hazardous materials, thus safeguarding their health. The growing emphasis on minimizing the risks associated with hazardous drug handling is boosting the demand for syringe adapters across hospitals and other healthcare institutions. As regulatory requirements tighten, the importance of these adapters in maintaining safety standards is expected to drive growth in this segment significantly.

Accessories:

Accessories for CSTDs encompass a range of supportive tools that enhance the functionality and effectiveness of the primary devices. These can include safety clamps, storage bags, and other enhancing components that ensure proper handling and storage of hazardous drugs. As healthcare systems increasingly incorporate CSTDs into their protocols, the market for accessories is also experiencing growth. These accessories not only support compliance with safety regulations but also provide healthcare workers with the necessary tools to effectively manage drug transfer, thus creating a safer working environment. The continuous innovation in accessory designs is expected to further stimulate market expansion.

By Application

Compounding:

Compounding is a critical application of CSTDs, as it involves the preparation of individualized medications for patients, especially those requiring chemotherapy. The use of CSTDs during the compounding process minimizes the risk of exposure to hazardous drugs and maintains a sterile environment. As the demand for personalized medicine grows, the need for efficient and safe compounding practices is expected to drive the CSTD market. Additionally, the growing number of compounding pharmacies is contributing to the significant expansion of this application segment.

Administration:

The administration of medications is one of the most vital applications for CSTDs, especially in clinical and hospital settings. These devices ensure that healthcare providers can safely administer hazardous drugs without risking exposure to harmful substances. As the number of patients requiring chemotherapy and other hazardous treatments increases, the demand for reliable drug administration systems is on the rise. Moreover, the emphasis on patient safety and reducing healthcare-associated infections further underscores the essential role of CSTDs in drug administration practices.

Drug Filling:

Drug filling is another key application area for closed system drug transfer devices, particularly relevant in pharmaceutical manufacturing and preparation facilities. CSTDs enable safe and efficient filling of vials and syringes with hazardous drugs, minimizing the risk of contamination and ensuring compliance with safety regulations. As the pharmaceutical industry continues to grow and evolve, the demand for safe drug filling processes is expected to rise, driving the need for effective CSTDs. Regulatory requirements regarding the handling of hazardous materials are also propelling growth in this application segment.

Sampling:

Sampling is an important aspect of drug development and quality control, particularly when dealing with hazardous substances. The use of CSTDs during the sampling process helps ensure that healthcare workers are protected from potential exposure while allowing for accurate and sterile sample collection. With the increasing focus on safety in laboratory practices, the adoption of CSTDs for sampling purposes is expected to grow. This application segment is likely to benefit from advancements in CSTD technology that enhance reliability and ease of use.

Others:

The 'Others' category encompasses various applications of CSTDs that do not fall into the primary classifications. This may include specialized uses in research laboratories, veterinary medicine, and other niche markets where drug safety is paramount. Although these applications may represent a smaller segment of the overall market, the increasing awareness of drug safety and the need for effective transfer devices across diverse fields is expected to contribute to the growth of the CSTD market. As more industries recognize the importance of safe drug handling, the demand for CSTDs in these areas is likely to rise.

By End User

Hospitals:

Hospitals are among the largest end users of closed system drug transfer devices due to the significant volume of hazardous drugs administered in these institutions. With a focus on patient safety and regulatory compliance, hospitals are increasingly adopting CSTDs to minimize the risk of exposure to harmful substances for both patients and healthcare personnel. The growing prevalence of chronic diseases requiring chemotherapy, along with the increasing number of surgical procedures, drives the demand for CSTDs within hospital settings. Furthermore, hospitals are continuously investing in advanced technologies to improve overall patient care, which is contributing to the growth of the CSTD market.

Clinics:

Clinics also represent a crucial segment of the CSTD market, particularly in the outpatient setting where chemotherapy and other hazardous drug therapies are administered. The adoption of CSTDs by clinics is driven by the need to ensure safety during drug transfer processes. As outpatient services continue to expand, particularly for oncology and pain management clinics, the demand for CSTDs is expected to rise. Moreover, the growing awareness among healthcare providers regarding the importance of safeguarding staff and patients from hazardous drug exposure is further fostering the adoption of CSTDs in clinic environments.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly leveraging closed system drug transfer devices as the number of outpatient surgeries continues to grow. CSTDs play a vital role in ensuring the safety of both patients and healthcare personnel during the administration of anesthetics and other hazardous medications. The convenience and efficiency offered by CSTDs enhance the operational capabilities of ASCs, allowing them to maintain high standards of safety and compliance. As ASCs seek to optimize their procedural capabilities while ensuring patient safety, the adoption of CSTDs is expected to increase significantly.

Pharmaceutical Companies:

Pharmaceutical companies are a significant driving force in the CSTD market, as they are responsible for the development, manufacturing, and distribution of hazardous drugs. The stringent regulations requiring safe handling practices compel these companies to invest in closed system drug transfer devices to ensure compliance and minimize risks. By using CSTDs throughout the drug production and filling processes, pharmaceutical companies can enhance safety and maintain product integrity. Moreover, the growing emphasis on research and development in the pharmaceutical industry is expected to further drive the adoption of CSTDs, as innovative drug formulations often require stringent safety measures.

Others:

The 'Others' category includes various end users of CSTDs, such as research laboratories and veterinary facilities. While these segments may represent a smaller portion of the market, they are gaining traction as safety standards around hazardous drug handling become more stringent. Research laboratories, in particular, require effective drug transfer solutions to ensure the safety of researchers and maintain sterile conditions during experiments. As awareness of drug safety continues to grow across different sectors, the demand for CSTDs among these end users is expected to increase in the coming years.

By Technology

Diaphragm-Based Devices:

Diaphragm-based devices are a prominent technology in the CSTD market, characterized by their unique design that minimizes the risk of drug exposure during transfer. These devices utilize a diaphragm that separates the drug transfer pathway from the external environment, creating a secure barrier against contamination. The increasing acceptance of diaphragm-based technologies is driven by the demand for reliable safety features in drug handling. As healthcare providers prioritize safety and compliance with regulatory guidelines, diaphragm-based CSTDs are likely to see significant adoption across hospitals and clinics.

Compartmentalized Devices:

Compartmentalized devices represent another significant technological advancement in the CSTD market. These devices are designed to segregate different components of the drug transfer process, preventing cross-contamination and ensuring the integrity of the medications being handled. The use of compartmentalized devices effectively enhances the safety of drug preparation and administration in healthcare settings. As the industry continues to evolve towards safer and more efficient drug handling solutions, the adoption of compartmentalized devices is expected to grow significantly, particularly in oncology and other specialized care units.

Air Cleaning/Filtration Devices:

Air cleaning and filtration devices play an essential role in maintaining a sterile environment during drug transfer processes. By effectively filtering airborne contaminants, these devices help reduce the risk of exposure to hazardous drugs for healthcare workers and patients. The increased focus on infection control and safety in healthcare settings is driving the demand for air cleaning and filtration technologies. As more institutions recognize the importance of maintaining a clean and safe environment for drug handling, the integration of air cleaning devices into CSTDs is expected to rise significantly.

Barrier Isolator Technology:

Barrier isolator technology offers a high level of protection during the drug transfer process by providing a sealed environment in which hazardous drugs can be handled without risk of exposure. This technology is particularly beneficial in sterile compounding and pharmaceutical manufacturing settings. As regulatory requirements continue to tighten around drug safety, barrier isolator technology is gaining traction as an effective solution for maintaining a closed system during drug preparation and administration. The increasing adoption of barrier isolators is expected to contribute significantly to the growth of the CSTD market.

Others:

The 'Others' category encompasses various emerging technologies in the CSTD market. This may include novel designs and innovative materials that enhance the safety and effectiveness of drug transfer systems. As research and development efforts in the healthcare sector expand, new technologies are expected to emerge, offering improved functionality and performance for CSTDs. The ongoing advancements in this area indicate a promising future for the CSTD market, where continuous innovation will be a key driver of growth and adoption.

By Region

The CSTD market exhibits significant regional variation, with North America being the largest market due to stringent safety regulations and a well-established healthcare system. In North America, the market is projected to reach USD 1.2 billion by 2035, growing at a CAGR of 8.9% over the forecast period. The increasing prevalence of cancer and chronic diseases, coupled with heightened awareness regarding occupational safety, drives the demand for CSTDs in this region. Healthcare providers in the U.S. and Canada are increasingly adopting closed system technology to comply with regulatory standards and enhance patient safety, which is propelling market growth.

In Europe, the CSTD market is also experiencing substantial growth, projected to reach USD 800 million by 2035, with a CAGR of 7.5%. The European market is characterized by a strong emphasis on safety regulations and guidelines, along with a growing number of healthcare facilities adopting CSTDs to ensure compliance. The increasing awareness of the risks associated with hazardous drug exposure among healthcare professionals is further fueling the adoption of CSTDs in the region. Meanwhile, the Asia Pacific region is expected to witness rapid growth, with projections of reaching USD 450 million by 2035, driven by the rising healthcare expenditure, increasing regulatory measures, and growing demand for safe drug handling practices among healthcare providers.

Opportunities

The CSTD market presents numerous opportunities for growth, particularly in emerging markets where healthcare infrastructure is rapidly evolving. Countries in the Asia Pacific region, such as India and China, are witnessing significant investments in healthcare facilities, leading to increased adoption of advanced medical technologies, including CSTDs. The rising incidence of chronic diseases in these regions is prompting healthcare providers to prioritize patient safety and compliance with international safety standards. As hospitals and clinics in these emerging markets recognize the importance of protecting healthcare personnel and patients from hazardous drug exposure, the demand for CSTDs is expected to rise significantly. This creates a favorable environment for manufacturers and suppliers to develop and market innovative closed system solutions tailored to the needs of these growing markets.

Another opportunity lies in the ongoing advancements in CSTD technology. As healthcare providers strive for greater efficiency and safety, the development of more sophisticated and user-friendly CSTDs presents an avenue for companies to differentiate themselves in the market. Innovations such as integrated air filtration systems and more effective drug transfer mechanisms can enhance the functionality of CSTDs, making them more appealing to end users. Additionally, educational initiatives aimed at increasing awareness of the importance of safe handling practices can create demand for CSTDs among healthcare providers who may not yet fully understand the benefits of these systems. By capitalizing on these technological advancements and education opportunities, companies can position themselves for growth in this dynamic market.

Threats

Despite the promising growth prospects for the CSTD market, several threats could impede its expansion. One notable threat is the potential for market saturation, particularly in developed regions where hospitals and clinics may already have implemented CSTDs. As the market matures, competition among existing players may intensify, leading to price wars that could negatively impact profit margins. Additionally, the emergence of alternative drug transfer solutions could pose a challenge to the CSTD market, particularly if these alternatives offer comparable safety and efficacy at lower costs. Manufacturers will need to continuously innovate and enhance their product offerings to maintain market share in the face of changing competitive dynamics.

Another significant threat to the CSTD market is related to regulatory challenges. The healthcare industry is subject to stringent regulations and guidelines, which can vary significantly by region. Companies operating in multiple markets may face difficulties in navigating these varying regulations, leading to potential delays in product approval and market entry. Furthermore, any changes in regulations could necessitate modifications to existing products, resulting in increased costs and resource allocation for manufacturers. Staying compliant with evolving regulations while ensuring product safety and efficacy will be crucial for companies operating in the CSTD market to mitigate these threats effectively.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Cardinal Health
• West Pharmaceutical Services
• Equashield
• Teva Pharmaceutical Industries Ltd.
• SurgiSys
• SmartSite
• Greiner Bio-One International GmbH
• Fresenius Kabi
• Corvida Medical
• McKesson Corporation
• Medline Industries, Inc.
• Halyard Health, Inc.
• Safe Handling Solutions, LLC
• Horizon Medical Products

The competitive landscape of the Closed System Drug Transfer Device market is characterized by a mix of well-established players and emerging companies that are striving to gain market share. Key companies in the market are leveraging technological advancements and innovative product development to differentiate themselves from competitors. With the increasing focus on patient safety and compliance with regulatory standards, manufacturers are investing in research and development to create more sophisticated and user-friendly devices that meet the evolving needs of healthcare providers. Mergers and acquisitions are also prevalent as companies seek to expand their product portfolios and gain access to new markets, thereby enhancing their competitive positioning in the CSTD market.

Among the major players, BD (Becton, Dickinson and Company) stands out as a leading manufacturer of medical devices, including CSTDs. The company has a strong commitment to innovation and safety, investing heavily in research and development to enhance its product offerings. BD's extensive portfolio and strong distribution network enable it to effectively reach a wide range of healthcare providers. Similarly, Cardinal Health is recognized for its comprehensive range of healthcare solutions, including CSTDs. The company's focus on safety and efficiency in drug handling positions it well in an increasingly competitive market. Through strategic partnerships and collaborations, these companies are continuously working to enhance their product capabilities and expand their market presence.

West Pharmaceutical Services is renowned for its advanced drug delivery systems, including CSTDs, that prioritize safety and efficacy. The company's emphasis on innovation and quality control has contributed to its strong standing in the market. Equashield is another notable player, specializing in closed system drug transfer technology specifically designed for oncology applications. The company’s commitment to patient safety and healthcare worker protection has allowed it to carve out a significant niche in the market. In a landscape where safety and compliance are paramount, these companies are not only competing on product features but also on their commitment to advancing the standards of drug handling in healthcare.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 SurgiSys
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 SmartSite
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Equashield
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Fresenius Kabi
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cardinal Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Corvida Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Halyard Health, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 McKesson Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Horizon Medical Products
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Safe Handling Solutions, LLC
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 West Pharmaceutical Services
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Greiner Bio-One International GmbH
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Closed System Drug Transfer Device CSTD Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Pharmaceutical Companies
    • 6.1.5 Others
  • 6.2 Closed System Drug Transfer Device CSTD Sales Market, By Technology
    • 6.2.1 Diaphragm-based Devices
    • 6.2.2 Compartmentalized Devices
    • 6.2.3 Air Cleaning/Filtration Devices
    • 6.2.4 Barrier Isolator Technology
    • 6.2.5 Others
  • 6.3 Closed System Drug Transfer Device CSTD Sales Market, By Application
    • 6.3.1 Compounding
    • 6.3.2 Administration
    • 6.3.3 Drug Filling
    • 6.3.4 Sampling
    • 6.3.5 Others
  • 6.4 Closed System Drug Transfer Device CSTD Sales Market, By Product Type
    • 6.4.1 Membrane-to-Membrane Systems
    • 6.4.2 Needleless Systems
    • 6.4.3 Phial Adapters
    • 6.4.4 Syringe Adapters
    • 6.4.5 Accessories

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Closed System Drug Transfer Device CSTD Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Closed System Drug Transfer Device CSTD Sales market is categorized based on

By Product Type

• Membrane-to-Membrane Systems
• Needleless Systems
• Phial Adapters
• Syringe Adapters
• Accessories

By Application

• Compounding
• Administration
• Drug Filling
• Sampling
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmaceutical Companies
• Others

By Technology

• Diaphragm-based Devices
• Compartmentalized Devices
• Air Cleaning/Filtration Devices
• Barrier Isolator Technology
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Cardinal Health
• West Pharmaceutical Services
• Equashield
• Teva Pharmaceutical Industries Ltd.
• SurgiSys
• SmartSite
• Greiner Bio-One International GmbH
• Fresenius Kabi
• Corvida Medical
• McKesson Corporation
• Medline Industries, Inc.
• Halyard Health, Inc.
• Safe Handling Solutions, LLC
• Horizon Medical Products